SC and A549 (lung epithelial cell-derived cell line routinely used to study ZIKV antiviral immunity) were treated with two doses of IFN-β before infection and we observed a significant reduction of ZIKV titers in a dose-dependent manner that was comparable in both cell types (Figure 1F). The gene discussed is IFNB1; the disease is infection.